Overview
The GMO U.S. Value ETF seeks to generate total return by investing primarily in U.S. equities.
GMO’s U.S. Value ETF seeks to profit from our Asset Allocation Team’s top-down insights as to the most attractively valued segment of the U.S. market. Currently, the team finds “deep value” (cheapest 20%) stocks to be truly dislocated in the U.S. This actively managed ETF avoids the “shallow value” stocks, which are expensive relative to their own history, and focuses solely on the deep value names. With this portfolio we focus on the U.S. stocks that GMO’s Systematic Equity team identifies as the most undervalued, recognizing that relying on reported financials and index definitions of value can lead investors to misjudge the opportunity.
Facts
Prices and Trading
| NAV as of 12/19/2024 | 24.19 |
| 1 Day NAV Change as of 12/19/2024 | -0.08 |
| Market Price | 24.21 |
| Premium/Discount | 0.06 % |
| 30 Day Median Bid/Ask Spread 1 | 0.08 % |
| 30 Day Average Share Volume 2 | 38591 |
1 Median 30 Day Bid/Ask Spread: An exchange traded fund's (“ETF”) median bid-ask spread, expressed as a percentage rounded to the nearest hundredth, is computed by identifying the ETF's national best bid and national best offer as of the end of each 10 second interval during each trading day of the last 30 calendar days; dividing the difference between each such bid and offer by the midpoint of the national best bid and national best offer; and identifying the median of those values. For the first 30 calendar days of trading, the median bid-ask spread for the ETF will reflect the number of calendar days the ETF has been operating.
2 30 Day Average Share Volume: The average number of shares traded in an ETF across all U.S. exchanges over the last 30 trading days. For the first 30 trading days, the volume of the ETF will reflect the number of trading days the ETF has been operating.
Performance
Fees and Expenses
| Expense Ratio 1 | 0.50 |
1 Expense Ratio is equal to the Fund’s Total Annual Operating Expenses set forth in the Fund’s most recent prospectus dated October 28, 2024.
Premium/Discount History
Documents
Literature
Downloads
| Performance | Download | |
| Portfolio Composition | Download | |
| Holdings | Download | |
| Download All | Download |
Commentary & Attribution
Investor Information
| Distribution Dates | Download | |
| Distribution Estimates | Download | |
| Download All | Download |
Risks
Risks associated with investing in the Fund may include: (1) Market Risk - Equities: The market price of equities may decline due to factors affecting the issuer, its industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Management and Operational Risk: The risk that GMO's investment techniques will fail to produce desired results, including annualized returns and annualized volatility. (3) Focused Investment Risk: The Fund invests its assets in the securities of a limited number of issuers, and a decline in the market price of a particular security held by the Fund may affect the Fund's performance more than if the Fund invested in the securities of a larger number of issuers.For a more complete discussion of these risks and others, please consult the Fund's Prospectus.
Disclosures
An investor should carefully consider the fund's investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund's prospectus. Read the prospectus carefully before investing. Please see the prospectus above.
The GMO ETFs are distributed in the United States by Foreside Fund Services LLC. GMO and Foreside Fund Services LLC are not affiliated.